Trinity Biotech Plc EBIT

Trinity Biotech Plc (TRIB) currently reports a EBIT of $-14M as of December 2025. That compares with $-16M in the prior-year period — up 16.3% year over year. That is below the Healthcare sector average of $22B. Use the charts on this page to explore Trinity Biotech Plc's EBIT history and peer comparisons.

Trinity Biotech Plc's EBIT increased from $-16M to $-14M — a 16.3% year-over-year increase (period ending December 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Trinity Biotech Plc's EBIT of $-14M is lower than the Healthcare sector average of $22B. That is roughly 100.1% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Trinity Biotech Plc reported $-14M in EBIT as of December 2025. That compares with $-16M in the prior-year period — up 16.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current EBIT of $-14M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $22B. From there, open related valuation or income-statement pages for Trinity Biotech Plc, and consider following TRIB for alerts when major investors trade the stock.